Oventus CEO and founder, Dr Chris Hart presented on 18 September, as part of a Micro/Small Cap “Hidden Gems” webinar hosted by ShareCafe.
During the presentation, Dr Hart covers:
- An overview of Obstructive Sleep Apnea (OSA)
- The significant market opportunity in treating OSA patients who are underserved by existing therapies
- The O2Vent treatment alternative to CPAP and clinical success rates
- The Lab in Lab model and telehealth implementation
- A summary of Oventus Medical’s recent progress and operational activity during COVID-19
- Oventus’ FY20 highlights
- The company’s strategic focus for FY2021
To watch the presentation, click play below.
Any investor queries can be directed to Jane Lowe via jane.lowe@irdepartment.com.au or +61 411 117 774.
Leave a Reply